Ezaki Glico
2206.TTSE PRIMEFoods
Filed as Ezaki Glico Co., Ltd. (2022-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥361.4bn | ¥331.1bn | ¥332.6bn | ¥303.9bn | ¥338.6bn | ¥344.0bn |
| Operating income | ¥8.7bn | ¥11.1bn | ¥18.6bn | ¥12.8bn | ¥19.3bn | — |
| Ordinary income | ¥11.6bn | ¥13.3bn | ¥21.3bn | ¥13.6bn | ¥21.7bn | ¥19.6bn |
| Net income (owners) | ¥5.0bn | ¥8.1bn | ¥14.1bn | ¥8.1bn | ¥13.5bn | ¥11.8bn |
| Total assets | ¥394.1bn | ¥377.8bn | ¥395.7bn | ¥369.1bn | ¥356.7bn | ¥340.1bn |
| Net assets / equity | ¥278.5bn | ¥272.6bn | ¥263.1bn | ¥244.8bn | ¥241.2bn | ¥222.6bn |
| Operating cash flow | ¥27.3bn | ¥1.8bn | ¥28.1bn | ¥16.8bn | ¥28.7bn | ¥17.2bn |
| EPS (basic) | ¥79.12 | ¥127.53 | ¥222.25 | ¥126.59 | ¥208.44 | ¥182.48 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 14
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 69 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 201 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 69 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 201 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 69 figures · EDINET |
| 2023-01-01 → 2023-12-31 | AnnualAmended | 201 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 45 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 201 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 47 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 71 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 45 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 201 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 47 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 71 figures · EDINET |
23 more reports are still being processed.
Segments · FY ended 2025-12
| Segment | External sales | Profit |
|---|---|---|
| Dairy Business | ¥66.5bn | −¥7.1bn |
| Food Ingredients Business | ¥13.2bn | ¥2.3bn |
| Health And Food Business | ¥47.9bn | −¥1.5bn |
| Nutritional Confectionery Business | ¥66.0bn | ¥4.4bn |
| Other Domestic Business | ¥77.2bn | ¥698m |
| Overseas Business | ¥90.7bn | ¥8.2bn |
| Adjustments & eliminations | — | ¥1.8bn |
| Total | ¥361.4bn | ¥6.9bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.